Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells
Language English Country England, Great Britain Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
11358989
Knihovny.cz E-resources
- MeSH
- fas Receptor metabolism MeSH
- Apoptosis * MeSH
- Cell Differentiation MeSH
- Antigens, CD biosynthesis MeSH
- Dimethyl Sulfoxide pharmacology MeSH
- HL-60 Cells MeSH
- Kinetics MeSH
- Culture Media, Serum-Free MeSH
- Humans MeSH
- RNA, Messenger MeSH
- Antibodies, Monoclonal metabolism MeSH
- Leukemia, Myeloid MeSH
- Protein Phosphatase 1 MeSH
- Proto-Oncogene Proteins c-bcl-2 biosynthesis metabolism MeSH
- Receptors, Tumor Necrosis Factor, Type II MeSH
- Receptors, Tumor Necrosis Factor biosynthesis MeSH
- Tumor Necrosis Factor-alpha pharmacology MeSH
- Carrier Proteins genetics metabolism MeSH
- Tretinoin pharmacology MeSH
- Protein Tyrosine Phosphatase, Non-Receptor Type 13 MeSH
- Protein Tyrosine Phosphatases genetics metabolism MeSH
- Up-Regulation MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- fas Receptor MeSH
- Antigens, CD MeSH
- Dimethyl Sulfoxide MeSH
- Culture Media, Serum-Free MeSH
- RNA, Messenger MeSH
- Antibodies, Monoclonal MeSH
- Protein Phosphatase 1 MeSH
- Proto-Oncogene Proteins c-bcl-2 MeSH
- PTPN13 protein, human MeSH Browser
- Receptors, Tumor Necrosis Factor, Type II MeSH
- Receptors, Tumor Necrosis Factor MeSH
- Tumor Necrosis Factor-alpha MeSH
- Carrier Proteins MeSH
- Tretinoin MeSH
- Protein Tyrosine Phosphatase, Non-Receptor Type 13 MeSH
- Protein Tyrosine Phosphatases MeSH
Differentiating myeloid cells may become resistant to various apoptotic stimuli. In the present study, dimethyl sulfoxide (DMSO) and all-trans retinoic acid (ATRA) were found to modulate the sensitivity of HL-60 cells to death receptor-mediated apoptosis in a time-dependent manner. During the early stages of differentiation, DMSO treatment increased the response of HL-60 cells to tumor necrosis factor alpha; (TNF-alpha), but enhanced responsiveness was lost during later differentiation stages. In contrast, ATRA treatment induced resistance to TNF-alpha-induced apoptosis. HL-60 cells were resistant to Fas-mediated apoptosis but were sensitized by culturing in serum-free conditions. Similar to its effect on TNF-alpha sensitivity, DMSO pretreatment augmented the response to Fas-mediated signaling, which coincided with increased expression of Fas on DMSO-pretreated cells. However, during the later stages of DMSO-induced differentiation, sensitivity to anti-Fas antibody-induced apoptosis declined significantly, although Fas expression was still elevated. The reduced sensitivity to anti-Fas treatment partially correlated with increased Fas-associated phosphatase-1 mRNA expression. Thus, regardless of either Fas up-regulation or potentiation of TNF-alpha-mediated apoptosis during early DMSO-induced differentiation, a slow increase in resistance to apoptosis mediated through these death receptors occurs during DMSO-induced differentiation, which contrasts with the rapid induction of resistance following treatment with ATRA.